FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991609908> ?p ?o ?g. }

• W1991609908 endingPage "432" @default.
• W1991609908 startingPage "424" @default.
• W1991609908 abstract "We have shown that Goto-Kakizaki (GK) rats, a lean model of type 2 diabetes, develop significant cerebrovascular remodeling by the age of 18 weeks, which is characterized by increased media thickness and matrix deposition. Although early glycemic control prevents diabetes-mediated remodeling of the cerebrovasculature, whether the remodeling can be reversed is unknown. Given that angiotensin II type 1 receptor blockers reverse pathologic vascular remodeling and function independent of changes in blood pressure in other vascular beds, we hypothesized that azilsartan medoxomil, a new angiotensin II type 1 receptor blocker, is vasculoprotective by preventing and reversing cerebrovascular remodeling in diabetes. Control Wistar and diabetic GK rats (n = 6–8 per group) were treated with vehicle (water) or azilsartan medoxomil (3 mg/kg/d) from the age of 14 to 18 or 18 to 22 weeks before or after vascular remodeling is established, respectively. Blood glucose and blood pressure were monitored and middle cerebral artery structure and function were evaluated using pressurized arteriography. Blood glucose was higher in GK rats compared with Wistar rats. Azilsartan treatment lowered blood glucose in diabetic animals with no effect on blood pressure. Diabetic animals exhibited lower myogenic tone, increased wall thickness, and cross-sectional area compared with control group animals, which were corrected by azilsartan treatment when started at the onset of diabetes or later after vascular remodeling is established. Azilsartan medoxomil offers preventive and therapeutic vasculoprotection in diabetes-induced cerebrovascular remodeling and myogenic dysfunction and this is independent of blood pressure. We have shown that Goto-Kakizaki (GK) rats, a lean model of type 2 diabetes, develop significant cerebrovascular remodeling by the age of 18 weeks, which is characterized by increased media thickness and matrix deposition. Although early glycemic control prevents diabetes-mediated remodeling of the cerebrovasculature, whether the remodeling can be reversed is unknown. Given that angiotensin II type 1 receptor blockers reverse pathologic vascular remodeling and function independent of changes in blood pressure in other vascular beds, we hypothesized that azilsartan medoxomil, a new angiotensin II type 1 receptor blocker, is vasculoprotective by preventing and reversing cerebrovascular remodeling in diabetes. Control Wistar and diabetic GK rats (n = 6–8 per group) were treated with vehicle (water) or azilsartan medoxomil (3 mg/kg/d) from the age of 14 to 18 or 18 to 22 weeks before or after vascular remodeling is established, respectively. Blood glucose and blood pressure were monitored and middle cerebral artery structure and function were evaluated using pressurized arteriography. Blood glucose was higher in GK rats compared with Wistar rats. Azilsartan treatment lowered blood glucose in diabetic animals with no effect on blood pressure. Diabetic animals exhibited lower myogenic tone, increased wall thickness, and cross-sectional area compared with control group animals, which were corrected by azilsartan treatment when started at the onset of diabetes or later after vascular remodeling is established. Azilsartan medoxomil offers preventive and therapeutic vasculoprotection in diabetes-induced cerebrovascular remodeling and myogenic dysfunction and this is independent of blood pressure." @default.
• W1991609908 created "2016-06-24" @default.
• W1991609908 creator A5039428519 @default.
• W1991609908 creator A5072730832 @default.
• W1991609908 creator A5084862427 @default.
• W1991609908 date "2014-11-01" @default.
• W1991609908 modified "2023-09-29" @default.
• W1991609908 title "Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes" @default.
• W1991609908 cites W1509722689 @default.
• W1991609908 cites W1744280301 @default.
• W1991609908 cites W1965523300 @default.
• W1991609908 cites W1969435326 @default.
• W1991609908 cites W1975898995 @default.
• W1991609908 cites W1978722589 @default.
• W1991609908 cites W1985560249 @default.
• W1991609908 cites W1993820363 @default.
• W1991609908 cites W1999064407 @default.
• W1991609908 cites W1999856629 @default.
• W1991609908 cites W2002555959 @default.
• W1991609908 cites W2005227667 @default.
• W1991609908 cites W2023654874 @default.
• W1991609908 cites W2027174334 @default.
• W1991609908 cites W2045696691 @default.
• W1991609908 cites W2046409398 @default.
• W1991609908 cites W2051956604 @default.
• W1991609908 cites W2052716928 @default.
• W1991609908 cites W2060979316 @default.
• W1991609908 cites W2067974747 @default.
• W1991609908 cites W2075054405 @default.
• W1991609908 cites W2088508460 @default.
• W1991609908 cites W2090037184 @default.
• W1991609908 cites W2111421663 @default.
• W1991609908 cites W2117324883 @default.
• W1991609908 cites W2118411978 @default.
• W1991609908 cites W2125928046 @default.
• W1991609908 cites W2127521475 @default.
• W1991609908 cites W2133217116 @default.
• W1991609908 cites W2136018315 @default.
• W1991609908 cites W2152798629 @default.
• W1991609908 cites W2161773090 @default.
• W1991609908 cites W2166890974 @default.
• W1991609908 cites W2172032309 @default.
• W1991609908 cites W2334233673 @default.
• W1991609908 doi "https://doi.org/10.1016/j.trsl.2014.06.003" @default.
• W1991609908 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4250409" @default.
• W1991609908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24999268" @default.
• W1991609908 hasPublicationYear "2014" @default.
• W1991609908 type Work @default.
• W1991609908 sameAs 1991609908 @default.
• W1991609908 citedByCount "13" @default.
• W1991609908 countsByYear W19916099082015 @default.
• W1991609908 countsByYear W19916099082016 @default.
• W1991609908 countsByYear W19916099082017 @default.
• W1991609908 countsByYear W19916099082018 @default.
• W1991609908 countsByYear W19916099082019 @default.
• W1991609908 countsByYear W19916099082020 @default.
• W1991609908 countsByYear W19916099082021 @default.
• W1991609908 countsByYear W19916099082022 @default.
• W1991609908 countsByYear W19916099082023 @default.
• W1991609908 crossrefType "journal-article" @default.
• W1991609908 hasAuthorship W1991609908A5039428519 @default.
• W1991609908 hasAuthorship W1991609908A5072730832 @default.
• W1991609908 hasAuthorship W1991609908A5084862427 @default.
• W1991609908 hasBestOaLocation W19916099082 @default.
• W1991609908 hasConcept C126322002 @default.
• W1991609908 hasConcept C134018914 @default.
• W1991609908 hasConcept C2777180221 @default.
• W1991609908 hasConcept C2780473172 @default.
• W1991609908 hasConcept C555293320 @default.
• W1991609908 hasConcept C71924100 @default.
• W1991609908 hasConcept C84393581 @default.
• W1991609908 hasConceptScore W1991609908C126322002 @default.
• W1991609908 hasConceptScore W1991609908C134018914 @default.
• W1991609908 hasConceptScore W1991609908C2777180221 @default.
• W1991609908 hasConceptScore W1991609908C2780473172 @default.
• W1991609908 hasConceptScore W1991609908C555293320 @default.
• W1991609908 hasConceptScore W1991609908C71924100 @default.
• W1991609908 hasConceptScore W1991609908C84393581 @default.
• W1991609908 hasFunder F4320332161 @default.
• W1991609908 hasIssue "5" @default.
• W1991609908 hasLocation W19916099081 @default.
• W1991609908 hasLocation W19916099082 @default.
• W1991609908 hasLocation W19916099083 @default.
• W1991609908 hasLocation W19916099084 @default.
• W1991609908 hasOpenAccess W1991609908 @default.
• W1991609908 hasPrimaryLocation W19916099081 @default.
• W1991609908 hasRelatedWork W1966504330 @default.
• W1991609908 hasRelatedWork W1966775726 @default.
• W1991609908 hasRelatedWork W1979139803 @default.
• W1991609908 hasRelatedWork W1991560548 @default.
• W1991609908 hasRelatedWork W2030889776 @default.
• W1991609908 hasRelatedWork W2037631372 @default.
• W1991609908 hasRelatedWork W2040058909 @default.
• W1991609908 hasRelatedWork W2132898409 @default.
• W1991609908 hasRelatedWork W2748952813 @default.
• W1991609908 hasRelatedWork W4249176446 @default.
• W1991609908 hasVolume "164" @default.
• W1991609908 isParatext "false" @default.

• next